Short Summary
Evac Oy, a Finnish company, brought an infringement action before the Local Chamber Düsseldorf against Shanghai VacDrain Vacuum Drainage Equipment Co., Ltd., VD Solutions GmbH, and Mr. Yong Cao concerning European Patents EP 1 840 282 B1 and EP 1 813 734 B1, both relating to vacuum sewer systems. The court addressed the applicability of the five-year limitation period under Article 72 UPCA, holding that it applies only to financial compensation claims and not to injunctive relief, which is forward-looking. The court found infringement of EP 1 840 282 B1 by Defendants 1 and 3, granted injunctive relief, recall and destruction orders, and ordered the defendants to pay damages, with costs split 70/30 in favor of the defendants.
Detailed Summary
This case was decided by the Local Chamber Düsseldorf (Lokalkammer Düsseldorf) of the Unified Patent Court under case number UPC_CFI_811/2024, with the decision announced on 22 June 2026 following an oral hearing on 19 May 2026. The presiding judge was Thomas (as rapporteur), joined by legally qualified judges Dr. Schumacher and Agergaard. The language of proceedings was German.
The claimant, Evac Oy, a Finnish company represented by its CEO Björn Ullbro, sued three defendants: (1) Shanghai VacDrain Vacuum Drainage Equipment Co., Ltd. (a Chinese company based in Shanghai), (2) VD Solutions GmbH (a German company based in Hamburg), and (3) Mr. Yong Cao (based in Budapest, Hungary). The action concerned alleged infringement of two European patents: EP 1 840 282 B1 ('Streitpatent I') and EP 1 813 734 B1 ('Streitpatent II'), both titled 'Vacuum sewer system.' Streitpatent I was filed on 8 February 2007 claiming priority from FI 20065209 of 31 March 2006, with grant published on 29 April 2015, and was in force in Germany, Finland, France, Italy, and the Netherlands. Streitpatent II was filed on 15 December 2006 claiming priority from FI 20065059 of 30 January 2006, with grant published on 9 November 2016, and was in force in Germany and Finland. An opt-out was filed for both patents on 9 June 2023 and withdrawn by the claimant on 14 December 2023.
Streitpatent I's claim 1 relates to a discharge valve including an aeration means for a vacuum sewer system, featuring a rapid vent valve with a valve plate that opens and closes against a valve seat to rapidly close the discharge valve after a discharge or flushing sequence. Streitpatent II's claim 1 relates to a vacuum sewer system comprising a vacuum buffer means with an active buffer device that changes modes to provide additional vacuum for governing the discharge valve.
The central legal issue addressed in the headnote concerned Article 72 UPCA, which provides that actions relating to all forms of financial compensation may not be brought more than five years after the applicant became aware, or had reasonable grounds to become aware, of the last fact justifying the action. The court held that this limitation period does not apply to injunctions, as an injunction is directed towards the future and is therefore not subject to the limitation period. The keywords identified were: limitation period, agreement, forfeiture, de facto business succession, and exhaustion of rights.
In its operative decision, the court found that Defendants 1 and 3 had infringed European Patent EP 1 840 282 B1 with respect to certain infringing products. The court granted injunctive relief prohibiting the defendants from offering, placing on the market, using, importing, exporting, or stocking the infringing products. The court also ordered Defendants 1 and 3 to recall the infringing products from commercial customers, to remove the products from distribution channels by informing commercial customers to cancel orders, and to destroy all infringing products in their possession. The defendants were ordered to provide information and accounting regarding the infringing acts and to compensate the claimant for damages.
The court imposed coercive penalties of at least EUR 1,000 per infringing product for violations of the injunction and at least EUR 500 per day for violations of the recall and destruction orders. The court further declared that Defendants 1 and 3 are liable in principle to compensate the claimant for any further damages arising from past and future infringing acts. The remainder of the claim was dismissed. Costs were allocated with the claimant bearing 30% and Defendants 1 and 3 bearing 70%. The dispute value was set at EUR 1,000,000. The orders under specific provisions were declared enforceable only after the claimant notified the court of which portions it intended to enforce and, where necessary, submitted certified translations.
What the Court Held — Ratio Decidendi
The court ruled that the limitation period for actions relating to financial compensation is five years, but this does not apply to injunctions. The court also found that the respondents had infringed the claimant's patents.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Evac Oy vs Shanghai VacDrain Vaccuum Drainage Equipment Co., Ltd., VD Solutions GmbH, Herrn Yong Cao is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Dolby International ABvsRoku, Inc.
This case concerns a review application by Roku, Inc. regarding an ex parte order granting Dolby International AB an Anti-Anti-Suit Injunction (AASI) and Anti-Anti-Enforcement Injunction (AAEI) before the Local Chamber Munich. The court declared the application for interim measures moot and the proceedings terminated, but held that Roku bore the costs because a prior cease-and-desist letter was unnecessary given Roku had already initiated US proceedings seeking Anti-Suit and Anti-Enforcement Injunctions against Dolby.
Genevant Sciences GmbH and Arbutus Biopharma CorporationvsModerna Group Entities (UPC_CFI_191/2025 and UPC_CFI_192/2025)
This procedural order of the Local Division The Hague concerns a Rule 333 review of a Judge Rapporteur's order on preliminary objections raised by 15 Moderna entities in two infringement actions brought by Genevant Sciences GmbH and Arbutus Biopharma Corporation concerning European patents EP 2 279 254 and EP 4 241 767. Moderna had challenged the court's international jurisdiction, local jurisdiction, and long-arm jurisdiction over various defendants. The full panel confirmed the Judge Rapporteur's order and dismissed Moderna's request for interim appeal.
Headwater Research LLCvsApple Inc. a. o.
Headwater Research LLC filed a patent infringement action against several Apple entities concerning European Patent EP 3 107 243 B1, and the Apple defendants filed a counterclaim for revocation. Prior to closure of the written procedure, the claimant withdrew the infringement action and the defendants withdrew the counterclaim for revocation, with both parties agreeing to bear their own costs and requesting reimbursement of 60% of court fees. The Düsseldorf Local Division allowed the withdrawals, declared the proceedings closed, and ordered each party to bear its own costs with 60% reimbursement of court fees.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.vsHMD Global Oy
The Local Chamber Hamburg of the Unified Patent Court issued a procedural order on August 21, 2025, rejecting the defendant's request to extend the deadline for filing its statement of defense by one month in a SEP infringement action concerning European Patent EP2380167. The defendant argued that the technical complexity of the MPEG-4 audio standard, the need to prepare a nullity counterclaim, the complexity of the FRAND defense involving pool negotiations, international litigation coordination, and school holidays of key personnel justified an extension. The court held that the three-month deadline under Rule 23 RoP is already calibrated to accommodate such circumstances, including vacation periods, and that the defendant had been aware of the licensing demands since 2017.
Labrador Diagnostics LLCvsbioMérieux SA and Others
Labrador Diagnostics LLC brought an infringement action against bioMérieux SA and five of its European subsidiaries concerning European patent EP 3 756 767 B1, which relates to instruments and methods for detecting biological analytes. The Düsseldorf Local Division bifurcated the case, referring the counterclaim for revocation to the Milan Central Division, which amended the patent to maintain only two claims. The court dismissed the infringement action, finding no direct or indirect infringement of the amended claims by the challenged VIDAS 3 instrument and related reagent strips and Solid Phase Receptacles, and ordered the Claimant to bear the costs.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.